Clinical Trial Update: XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of XC8 for eosinophilic bronchial asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma
• Eosinophilic Bronchial Asthma

Drugs mentioned

• XC8

Snippet

Sponsor: Chemlmmune Therapeutics LLC | Conditions: Bronchial Asthma, Eosinophilic Asthma | Phase 2 | Status: COMPLETED